Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis
Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
This study intends to measure the effects of valsartan/sacubitril compared to baseline
standard medical heart failure therapy on reverse remodeling using echocardiographic
endocardial surface analysis techniques to assess changes in ventricular volume, function,
and shape.
Phase:
Phase 4
Details
Lead Sponsor:
University of Chicago
Treatments:
LCZ 696 Sacubitril and valsartan sodium hydrate drug combination Valsartan